Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
13.64
+0.17 (+1.26%)
Streaming Delayed Price
Updated: 10:24 AM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS
December 04, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
These biotechs targeting multiple neurodegenerative diseases
December 01, 2023
A growing number of up-and-coming biotech firms are demonstrating the value of expanding a drug's total addressable market.
Via
MarketBeat
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Earnings Preview For Amylyx Pharma
↗
November 08, 2023
Via
Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
↗
November 28, 2023
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.
Via
InvestorPlace
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer
November 28, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND
November 27, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Expert Ratings for Amylyx Pharma
↗
August 11, 2023
Via
Benzinga
A Preview Of Amylyx Pharma's Earnings
↗
August 09, 2023
Via
Benzinga
Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Amylyx Stockholders and Encourages Investors to Contact the Firm
November 15, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Amylyx Pharmaceuticals, Inc. (AMLX)
November 14, 2023
From
Kirby McInerney LLP
Via
Business Wire
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles
↗
November 09, 2023
The company says patient discontinuations mounted in the quarter.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 09, 2023
Via
Benzinga
Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023
November 02, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Present Clinical Trial Design of ORION, a Phase 3 Global Study of AMX0035 in Progressive Supranuclear Palsy (PSP), at the Neuro2023 PSP and CBD International Research Symposium
October 19, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
3 Under-the-Radar Biotech Stocks to Buy in 2023
↗
October 19, 2023
These three lesser-known biotech companies are profitable and growing revenue.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
October 18, 2023
Via
Benzinga
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
October 13, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now
↗
October 10, 2023
These two high-tech bio companies may be too cheap to ignore right now.
Via
The Motley Fool
Amylyx Pharmaceuticals Announces Publication of Survival Analysis Comparing CENTAUR to Historical Clinical Trial Control
October 10, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals Provides Update on Accès Compassionnel for AMX0035 in France
October 05, 2023
From
Amylyx Pharmaceuticals
Via
Business Wire
RELYVRIO® and AMX0114 Data to be Presented at 22nd Annual Northeast ALS Consortium (NEALS) Meeting
October 02, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
September 05, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
↗
August 28, 2023
Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.
Via
InvestorPlace
Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 10, 2023
August 03, 2023
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
3 Biotech Stocks to Buy Before Drug Trials End
↗
July 28, 2023
Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.
Via
InvestorPlace
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
